US$ 28.63
fda statement on compounded semaglutide is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before FDA says 'no clinical need'
Description
No pharmacy games

However, some doctors will prescribe it to people who are overweight or obese and have type 2 diabetes or prediabetes

doi:10.1242/jeb.00861

Kristensson, K., Nordborg, C., Olsson, Y

The SURMOUNT program The SURMOUNT trials represent the largest body of clinical evidence for tirzepatide in weight management

Over 30% of Americans are interested in using a GLP-1, and 40 million people worldwide are expected to be on one of these medications by 2029
